Logo

American Heart Association

  2
  0


Final ID: Mo3002

Insulin Resistance as a Marker of Multivessel Coronary Artery Diseases in Patients With Cardiovascular-Kidney-Metabolic Risk: Inshight From Invasive Coronary Angiography

Abstract Body (Do not enter title and authors here): Background: Cardiovascular-Kidney-Metabolic (CKM) syndrome is the concept of a combined diseases, including diabetes and chronic kidney disease (CKD), to stratify patients at cardiovascular risks. However, whether CKM components and insulin resistance differ in risk for coronary artery disease (CAD) severity is unknown.
Purpose: This study aimed to investigate the association of distinct CKM risks and insulin resistance with CAD severity.
Methods: In this study, we included 849 patients (74% male, 69±10 years of age) who underwent coronary angiography to assess chronic CAD. We assessed CKM risks using following components: (1) BMI ≥23 kg/m2, (2) diabetes, (3) hypertension and dyslipidemia, and (4) CKD. According to the number of CKM risk components, patients were categorized into four groups (Group A as having 0 or 1, Group B as 2, Group C as 3, and Group 4 as 4 risks). Insulin resistance was assessed by HOMA-IR and triglyceride-glucose index (TyG index) calculated as Ln (fasting plasma glucose × triglyceride/2). Coronary artery stenosis was categorized into single-vessel or multi-vessel CAD (MVD) per AHA classification. Gensini score was calculated to assess CAD extent. Logistic regression analysis was performed to determine independent predictors of MVD among CKM risk components.
Results: MVD was diagnosed in 26.3% (n = 223) patients (mean Gensini score was 58±40 points). Among the four groups, there were significant differences in age, body mass index, hemoglobin A1c levels, TyG index, HOMA-IR, and Gensini score. Compared with Group A as reference, Group C (odds ratio [OR], 1.58; 95% confidence interval [CI] 1.03–2.42) or Group D (OR, 1.75; 95%CI, 1.06–2.89) but not Group B (OR, 1.09; 95%CI, 0.70–1.71) had higher risk for MVD (Figure). In a logistic regression model adjusting for age, male, smoker, and CRP ≥2 mg/dL, independent predictor of MVD was diabetes (OR, 2.15; 95%CI,1.55–2.99; p < 0.001; model 1 in Table). In addition, when adjusting for age, male, smoker, and CRP ≥2 mg/dL, HOMA-IR>2.5 was an independent predictor of MVD (model 2 in Table). Similarly, TyG index, an alternative marker of insulin resistance, remained as an independent predictor of MVD (model 3 in Table).
Conclusions: In chronic CAD patients who underwent coronary angiography, subgroups stratified by the CKM risk components exhibit distinctly different insulin resistance, CAD severity and risk for MVD. Insulin resistance and diabetes were independent risks for MVD in this population.
  • Fujisawa, Naoki  ( Osaka Metropolitan University , Osaka , Japan )
  • Yamazaki, Takanori  ( Osaka Metropolitan University , Osaka , Japan )
  • Fukuda, Daiju  ( Osaka Metropolitan University , Osaka , Japan )
  • Otsuka, Kenichiro  ( Osaka Metropolitan University , Osaka , Japan )
  • Yamaura, Hiroki  ( Osaka Metropolitan University , Osaka , Japan )
  • Okamoto, Akihiro  ( Osaka Metropolitan University , Osaka , Japan )
  • Yamaguchi, Tomohiro  ( Osaka Metropolitan University , Osaka , Japan )
  • Kagawa, Shunsuke  ( Osaka Metropolitan University , Osaka , Japan )
  • Shimada, Takenobu  ( Osaka Metropolitan University , Osaka , Japan )
  • Shibata, Atsushi  ( Osaka Metropolitan University , Osaka , Japan )
  • Ito, Asahiro  ( Osaka Metropolitan University Graduate School of Medicine , Osaka, , Japan )
  • Author Disclosures:
    NAOKI FUJISAWA: DO NOT have relevant financial relationships | Takanori Yamazaki: DO NOT have relevant financial relationships | Daiju Fukuda: DO NOT have relevant financial relationships | Kenichiro Otsuka: DO NOT have relevant financial relationships | Hiroki Yamaura: No Answer | Akihiro Okamoto: No Answer | Tomohiro Yamaguchi: DO NOT have relevant financial relationships | Shunsuke Kagawa: DO NOT have relevant financial relationships | Takenobu Shimada: DO NOT have relevant financial relationships | Atsushi Shibata: DO NOT have relevant financial relationships | Asahiro Ito: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

What’s New in Cardiovascular Outcomes in Diabetes

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
84 Immune checkpoint profiling in major aortic diseases leads to identification of potential roles of CD155-CD206 pathway in suppressing inflammation and immune responses

Shao Ying, Saaoud Fatma, Xu Keman, Lu Yifan, Jiang Xiaohua, Wang Hong, Yang Xiaofeng

Absence of standard modifiable risk factors (SMuRF-less) among 5002 Middle Eastern patients with atherosclerotic cardiovascular disease: (Interim analysis from the Jo-SMuRF Study)

Aldalal'ah Mo'men, Hammoudeh Ayman, Hamza Ibrahem, Alqudah Mohammad, Khasawneh Hasan, Alomari Sawsan, Alomari Ahmad, H. Assaf Sarah, Zaqqa Ayah, Khatatbeh Moawiah

More abstracts from these authors:
Pericoronary Adipose Tissue Inflammation as a Marker of Increased Coronary Plaque Burden in Patients With Chronic Coronary Artery Disease With Zero Calcium Score

Otsuka Kenichiro, Shimada Takenobu, Shibata Atsushi, Ito Asahiro, Yamazaki Takanori, Fukuda Daiju, Yamaura Hiroki, Fujisawa Naoki, Ishikawa Hirotoshi, Hojo Kana, Matsumoto Kotaro, Okamoto Akihiro, Yamaguchi Tomohiro, Kagawa Shunsuke

Atherosclerotic plaque healing as a marker of plaque vulnerability: Insight from intracoronary polarization-sensitive optical frequency domain imaging

Fujisawa Naoki, Shimada Takenobu, Shibata Atsushi, Ito Asahiro, Yamazaki Takanori, Bouma Brett, Fukuda Daiju, Otsuka Kenichiro, Villiger Martin, Jones Georgia, Sugioka Kazuya, Yamaura Hiroki, Okamoto Akihiro, Yamaguchi Tomohiro, Kagawa Shunsuke

You have to be authorized to contact abstract author. Please, Login
Not Available